Clinical Trial Update: Phase I Trial of CArbonic Anhydrase Inhibition in Combination With Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma [Phase 1]

View source ↗

Summary

Phase I clinical trial update for an investigational carbonic anhydrase inhibitor in combination with radiochemotherapy or radioimmunotherapy for small cell lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Carbonic anhydrase inhibitor (investigational)

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Small Cell Lung Cancer | Phase 1 | Status: RECRUITING